NGM BIOPHARMACEUTICALS INC - COM (NGM)

CUSIP: 62921N105

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -34,417,007
Total reported value: $0
Number of holders: 0
Value change: -$54,723,051
Number of sells: 68

Quarterly Holders Quick Answers

What is CUSIP 62921N105?
CUSIP 62921N105 identifies NGM - NGM BIOPHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2024

Recent filing periods for CUSIP 62921N105:

Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022

There are no holders of NGM - NGM BIOPHARMACEUTICALS INC - COM as of Q2 2024.